Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionNilsine Partners, LLC
Latest Disclosed Ownership16,649 shares
Latest Disclosed Value $ 2,126,875
Nilsine Partners, LLC reports 7.48% increase in ownership of GILD / Gilead Sciences, Inc.

On April 29, 2026 - Nilsine Partners, LLC filed a 13F-HR form disclosing ownership of 16,649 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,126,875 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 15,491 shares of Gilead Sciences, Inc.. This represents a change in shares of 7.48% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 16,649 1,158 7.48 2,127 11.84 0.1662
2026-01-15 2025-12-31 13F GILEAD SCIENCES COM 375558103 15,491 1,412 10.03 1,901 21.70 0.1647
2025-10-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 14,079 1,466 11.62 1,563 11.73 0.1405
2025-07-31 2025-06-30 13F GILEAD SCIENCES COM 375558103 12,613 10,757 579.58 1,398 575.36 0.1413
2025-04-22 2025-03-31 13F GILEAD SCIENCES COM 375558103 1,856 1,856 208 0.0228
2024-07-31 2024-06-30 13F GILEAD SCIENCES COM 375558103 0 -13,216 -100.00 0 -100.00
2024-04-22 2024-03-31 13F GILEAD SCIENCES COM 375558103 13,216 790 6.36 968 -3.78 0.1322
2024-01-24 2023-12-31 13F GILEAD SCIENCES COM 375558103 12,426 532 4.47 1,007 12.91 0.1547
2023-11-01 2023-09-30 13F GILEAD SCIENCES COM 375558103 11,894 127 1.08 891 -1.66 0.1348
2023-07-21 2023-06-30 13F GILEAD SCIENCES COM 375558103 11,767 30 0.26 907 -6.89 0.1333
2023-05-10 2023-03-31 13F GILEAD SCIENCES COM 375558103 11,737 11,737 974 0.1526
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.